How have NXL shares performed in 2024?

Nexalin Technology's stock was trading at $0.4048 at the beginning of 2024. Since then, NXL stock has increased by 243.4% and is now trading at $1.3901. View the best growth stocks for 2024 here .

Are investors shorting Nexalin Technology?

Nexalin Technology saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 95,200 shares, a decrease of 40.7% from the March 15th total of 160,500 shares. Based on an average daily trading volume, of 748,000 shares, the short-interest ratio is currently 0.1 days. Approximately 1.6% of the company's stock are short sold. View Nexalin Technology's Short Interest .

When is Nexalin Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our NXL earnings forecast .

When did Nexalin Technology IPO?

Nexalin Technology (NXL) raised $10 million in an initial public offering on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $4.15 per share.

How do I buy shares of Nexalin Technology?

Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NXL

Nexalin Technology (NXL) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free NXL Stock Alerts

$1.40

-0.07 (-4.42%)

(As of 02:01 PM ET)

Compare

Today's Range: $1.08
▼
$1.42
50-Day Range: $0.30
▼
$2.87
52-Week Range: $0.25
▼
$3.40

Volume: 233,352 shs
Average Volume: 672,949 shs
Market Capitalization: $10.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Nexalin Technology alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Nexalin Technology Stock (NASDAQ:NXL)

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

NXL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NXL Stock News Headlines

April 12, 2024 | investing.com

Nexalin Technology advances in mental health treatment

April 11, 2024 | americanbankingnews.com

Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 10, 2024 | globenewswire.com

Nexalin Technology CEO Provides Letter to Shareholders

April 6, 2024 | stockhouse.com

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity(TM), a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

April 4, 2024 | globenewswire.com

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

April 2, 2024 | proactiveinvestors.com

Nexalin Technology's neurostimulation device shows promise in easing mTBI symptoms in veterans

April 2, 2024 | globenewswire.com

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 30, 2024 | finance.yahoo.com

Nexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022)

March 28, 2024 | globenewswire.com

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

March 14, 2024 | finance.yahoo.com

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology

March 14, 2024 | globenewswire.com

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology

March 13, 2024 | globenewswire.com

Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”

March 6, 2024 | globenewswire.com

Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia

February 8, 2024 | finance.yahoo.com

Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device

January 23, 2024 | finance.yahoo.com

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System

January 17, 2024 | morningstar.com

Nexalin Technology Inc NXL

January 11, 2024 | stockhouse.com

Nexalin Technology Unveils Next-Generation HALO(TM) Clarity

January 11, 2024 | finance.yahoo.com

Nexalin Technology Unveils Next-Generation HALO™ Clarity

December 18, 2023 | finance.yahoo.com

Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression

October 16, 2023 | finance.yahoo.com

Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures

September 14, 2023 | barrons.com

Nexalin Technology Inc.

August 7, 2023 | finance.yahoo.com

Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms

August 3, 2023 | finance.yahoo.com

Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time

July 27, 2023 | finance.yahoo.com

Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies

July 10, 2023 | finance.yahoo.com

Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury

See More Headlines

Receive NXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Business Services
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:NXL
CUSIP: N/A
CIK: 1527352
Web: www.nexalin.com
Phone: 832-260-0222
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,650,000.00
Net Margins: -4,185.46%
Pretax Margin: -4,197.82%
Return on Equity: -122.57%
Return on Assets: -97.00%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.07
Quick Ratio: 7.70

Sales & Book Value

Annual Sales: $110,000.00
Price / Sales: 94.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.43 per share
Price / Book: 3.23

Miscellaneous

Outstanding Shares: 7,440,000
Free Float: 5,378,000
Market Cap: $10.34 million
Optionable: Not Optionable
Beta: 6.34

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Ms. Marilyn Elson (Age 71)
Controller
Comp: $382.72k
Mr. Mark White (Age 62)
President, CEO, CFO & Director
Comp: $191.29k
Mr. John Patrick Claude
Co-Founder and Director of Engineering & Development
Dr. David Owens M.D. (Age 63)
Chief Medical Officer & Director
Mr. Michael Nketiah (Age 48)
Senior Vice-President of Quality, Regulatory & Clinical Affairs
Comp: $251.6k

Key Competitors

View All Competitors

NXL Stock Analysis - Frequently Asked Questions

How have NXL shares performed in 2024?: Nexalin Technology's stock was trading at $0.4048 at the beginning of 2024. Since then, NXL stock has increased by 243.4% and is now trading at $1.3901.
View the best growth stocks for 2024 here.
Are investors shorting Nexalin Technology?: Nexalin Technology saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 95,200 shares, a decrease of 40.7% from the March 15th total of 160,500 shares. Based on an average daily trading volume, of 748,000 shares, the short-interest ratio is currently 0.1 days. Approximately 1.6% of the company's stock are short sold.
View Nexalin Technology's Short Interest.
When is Nexalin Technology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our NXL earnings forecast.

When did Nexalin Technology IPO?: Nexalin Technology (NXL) raised $10 million in an initial public offering on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $4.15 per share.
How do I buy shares of Nexalin Technology?: Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NXL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nexalin Technology (NXL) Stock Price, News & Analysis

About Nexalin Technology Stock (NASDAQ:NXL)

NXL Stock Price History

NXL Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

NXL Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info